GlassScriptPhysician profile
Elliott Groves
NPI 1154550119
$31,104.98
in general payments reported to CMS, 2019-2025
16 companies · $4,441 in 2025
The $4,441 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,580 · 2020: $4,990 · 2021: $746 · 2022: $3,795 · 2023: $7,162 · 2024: $3,391 · 2025: $4,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,938 · Food and Beverage: $4,065 · Travel and Lodging: $3,252 · Consulting Fee: $1,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,937.50 |
| Food and Beverage | $4,064.87 |
| Travel and Lodging | $3,251.93 |
| Consulting Fee | $1,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,240.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,811.98 | 2019-2025 | Diamondback Coronary, Xience Skypoint, Triclip |
| Cardiovascular Systems INC. | $9,734.59 | 2019-2023 | Diamondback Coronary |
| Boston Scientific Corporation | $2,690.50 | 2019-2025 | Watchman Flx, Watchman Access System, General - Therapies |
| Edwards Lifesciences Corporation | $2,521.54 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $1,448.45 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $874.71 | 2019-2020 | |
| Acist Medical Systems, INC. | $846.73 | 2021-2023 | |
| Abiomed | $570.37 | 2019-2022 | |
| Shockwave Medical, INC | $298.45 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Seigla Medical, INC. | $86.43 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $69.74 | 2019 | |
| Cvrx, INC. | $45.86 | 2022 | |
| Biotronik INC. | $42.36 | 2022 | |
| Philips North America LLC | $22.29 | 2023 | |
| Novartis Pharmaceuticals Corporation | $21.11 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $19.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.